Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

CANG vs CD: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CD Captures Overall Composite Edge (57.8 HOLD vs 51.3 HOLD), While CANG Leads 3–2 on Growth & Valuation Pillars

CD Overall Winner 6-Pillar Tally: CANG 3 – 2 CD (1 Tie) Matrix Metrics: CANG 4 – 6 CD

As of Nov 19, 2026, CD (CD) captures the overall head-to-head institutional edge over Cango Inc. (CANG) on higher Unified Composite conviction (57.8/100 HOLD vs. 51.3/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while CANG wins 3–2 across the 6-pillar growth and valuation breakdown. CANG trades at $1.64 (3.1x Forward P/E, -11.1% operating margin) versus CD at $3.83 (N/M Forward P/E, -80.5% operating margin).

  • Growth vs. Quality Trade-Off: CD earns the overall head-to-head edge with a stronger Unified Composite Score (57.8/100 HOLD vs. CANG 51.3/100 HOLD) and 2.44β · 160% Vol risk profile, whereas CANG leads top-line expansion (-33.2% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CANG vs CD
CANG NYSE
Cango Inc. American Depositary Shares, each representing two (2) Class A Ordinary Shares
Services-Prepackaged Software
$1.64
+10.81% 1D
Market Cap $60.7M
TTM Revenue $557M
Forward P/E 3.1x
Beta / 30D Vol 8.01β · 222% Vol
Unified Composite Score
51.3 / 100 HOLD
Tech 55.0 Fund 51.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 46
RSI-14: 45.6 · SMA20: $1.31 · SMA50: $2.08
CD US Equity Head-to-Head Winner
CD
Institutional Equity
$3.83
-4.73% 1D
Market Cap $442.2M
TTM Revenue $3.4M
Forward P/E N/M
Beta / 30D Vol 2.44β · 160% Vol
Unified Composite Score
57.8 / 100 HOLD
Tech 65.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 37
RSI-14: 37.1 · SMA20: $6.10 · SMA50: $6.14

6-Pillar Scorecard Institutional Category Breakdown (CANG 3 – 2 CD)

Columns: Metric · CANG · CD
1. Valuation Multiples CANG
Forward P/E 3.1x N/M
Trailing P/E 3.1x N/M
PEG Ratio N/M N/M
EV / Revenue 0.2x 128.3x
2. Growth & Scale CD
Revenue Growth (YoY) -33.2% +92.0%
Earnings Growth (YoY) +137.3% +0.0%
TTM Revenue (USD) $557M $3.4M
Market Cap $60.7M $442.2M
3. Profitability & Quality CD
Gross Margin -5.4% 63.1%
Operating Margin -11.1% -80.5%
Net Profit Margin -107.2% -56.0%
Return on Equity (ROE) -151.0% -7.7%
4. Balance Sheet & Cash Flow CANG
Cash Generation (TTM) $71M EBITDA -$4.5M EBITDA
Cash Flow Margin 12.7% EBITDA Mgn -130.3% EBITDA Mgn
Net Cash / Leverage $26M Net Debt (0.16x D/E) $0.56 Book/Sh · -7.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 126.6% (<1st %ile)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat CANG
OpEx & R&D Intensity 5.7% of Rev ($32M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Capital Markets Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CANG (4) vs CD (6)
Institutional Metric CANG CD Criterion Row Edge
Market Capitalization
Scale
$60.7M $442.2M Larger Scale CD
Trailing P/E Ratio
Valuation
3.1x N/M Lower Multiple CANG
Forward P/E Ratio
Valuation
3.1x N/M Lower Multiple CANG
Revenue Growth (YoY)
Growth
-33.2% +92.0% Higher Growth CD
Operating Margin (TTM)
Profitability
-11.1% -80.5% Higher Margin CANG
Net Profit Margin
Profitability
-107.2% -56.0% Higher Margin CD
Return on Equity (ROE)
Capital Efficiency
-151.0% -7.7% Higher ROE CD
52-Week Range Position
Momentum
37% ($0–$4) 14% ($2–$14) Stronger Trend CANG
Beta / 30D Volatility
Risk Regime
8.01β · 222% Vol 2.44β · 160% Vol Lower Realized Risk CD
Unified Institutional Score
Composite Signal
51.3 / 100 (HOLD) 57.8 / 100 (HOLD) Higher Composite CD
Trailing 12M Revenue (USD)
Operating Scale
$557M $3.4M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
-5.4% 63.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.2x EV/Rev N/M PEG · 128.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$71M EBITDA ($26M Net Debt (0.16x D/E)) -$4.5M EBITDA ($0.56 Book/Sh · -7.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CANG +20.42 pp
CANG: -29.61% · CD: -50.03%
3M Horizon CD +30.05 pp
CANG: -23.36% · CD: +6.69%
6M Horizon CANG +273.65 pp
CANG: +214.18% · CD: -59.47%
1Y Horizon CANG +63.07 pp
CANG: +6.49% · CD: -56.58%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CANG vs CD. Trailing 12-month operating profitability (CANG -11.1% vs CD -80.5%) and valuation multiples (CANG 3.1x vs CD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CANG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$557M
Gross Margin-5.4%
Op. Margin-11.1%
ROE / Fwd P/E-151.0% · 3.1x
CD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.4M
Gross Margin63.1%
Op. Margin-80.5%
ROE / Fwd P/E-7.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CANG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CANG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 126.6%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CANG Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $60.7M market capitalization and -11.1% operating margin.
OpEx & R&D Reinvestment 5.7% of Rev ($32M)
90D Engineering Disclosures 0 Published
CD Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $442.2M market capitalization and -80.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CANG vs CD Key Questions & Quantitative Answers

As of Nov 19, 2026, CD (CD) captures the overall head-to-head institutional edge over Cango Inc. (CANG) on higher Unified Composite conviction (57.8/100 HOLD vs. 51.3/100 HOLD) after splitting the core matrix 6–4 (led by Growth & Scale, Profitability & Quality), while CANG wins 3–2 across the 6-pillar growth and valuation breakdown. CANG trades at $1.64 (3.1x Forward P/E, -11.1% operating margin) versus CD at $3.83 (N/M Forward P/E, -80.5% operating margin). Growth vs. Quality Trade-Off: CD earns the overall head-to-head edge with a stronger Unified Composite Score (57.8/100 HOLD vs. CANG 51.3/100 HOLD) and 2.44β · 160% Vol risk profile, whereas CANG leads top-line expansion (-33.2% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.

CD leads the Growth & Scale pillar: CANG posts -33.2% YoY revenue growth and +137.3% YoY earnings growth on $557M TTM revenue (-5.4% gross margin, -11.1% operating margin), compared with CD at +92.0% YoY revenue growth and +0.0% YoY earnings growth on $3.4M TTM revenue (63.1% gross margin, -80.5% operating margin). On trailing 12-month operating scale, CANG generates $557M in USD-normalized revenue versus $3.4M for CD. In operating R&D and SG&A reinvestment, CANG deploys 5.7% of Rev ($32M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CD.

CANG screens cheaper on headline valuation multiples. CANG trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.2x EV/Revenue (12.7% EBITDA margin), whereas CD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 128.3x EV/Revenue (-130.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CANG (-151.0% ROE) versus CD (-7.7% ROE) capital efficiency.

In options market volatility and institutional positioning, CANG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (8.01β · 222% Vol realized risk). By comparison, CD carries 126.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.44β · 160% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.